Olanzapine for the treatment of chronic refractory schizophrenia: a 12-month follow-up naturalistic study.
Rodríguez-Pérez V, López A, Blanco C, Peña C, López A, Abel A, Gómez Y, Ferreiro MJ, Rego C, López A, Cudeiro F, Alvarez V, Prieto R, Ciudad A.
Rodríguez-Pérez V, et al. Among authors: ferreiro mj.
Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1055-62. doi: 10.1016/s0278-5846(02)00222-1.
Prog Neuropsychopharmacol Biol Psychiatry. 2002.
PMID: 12452526
Clinical Trial.